| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,856 |
14,946 |
$2.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,422 |
6,844 |
$1.42M |
| X4011 |
State-specific procedure code |
4,688 |
4,062 |
$944K |
| Y7506 |
|
4,948 |
3,216 |
$444K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,305 |
11,814 |
$429K |
| 80053 |
Comprehensive metabolic panel |
12,707 |
11,408 |
$407K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,266 |
3,416 |
$325K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
881 |
809 |
$267K |
| 81000 |
|
6,597 |
6,114 |
$245K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,808 |
2,562 |
$200K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,549 |
4,344 |
$157K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,619 |
1,524 |
$129K |
| 36415 |
Collection of venous blood by venipuncture |
8,622 |
7,229 |
$125K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
598 |
594 |
$120K |
| 71045 |
Radiologic examination, chest; single view |
1,872 |
1,739 |
$90K |
| 71046 |
Radiologic examination, chest; 2 views |
421 |
408 |
$61K |
| 84484 |
|
2,208 |
1,997 |
$53K |
| G0378 |
Hospital observation service, per hour |
117 |
96 |
$38K |
| 82550 |
|
1,484 |
1,362 |
$35K |
| 82553 |
|
976 |
902 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
361 |
320 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,380 |
1,280 |
$19K |
| J3490 |
Unclassified drugs |
5,904 |
2,566 |
$18K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
99 |
91 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,032 |
978 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,019 |
1,003 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
125 |
109 |
$12K |
| 83874 |
|
194 |
177 |
$11K |
| 83605 |
|
326 |
301 |
$8K |
| 80061 |
Lipid panel |
726 |
682 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
247 |
232 |
$6K |
| 83880 |
|
253 |
228 |
$6K |
| 87807 |
|
431 |
426 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
121 |
113 |
$5K |
| 87040 |
|
40 |
38 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
41 |
39 |
$4K |
| 84439 |
|
481 |
446 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
25 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15 |
12 |
$3K |
| 87186 |
|
55 |
52 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
115 |
104 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
262 |
239 |
$2K |
| 82607 |
|
154 |
141 |
$2K |
| 83735 |
|
308 |
268 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13 |
12 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
17 |
17 |
$964.62 |
| 83721 |
|
80 |
76 |
$871.92 |
| 85610 |
|
69 |
64 |
$820.19 |
| 85730 |
|
53 |
49 |
$804.25 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
13 |
$549.74 |
| 83690 |
|
101 |
90 |
$408.04 |
| 82150 |
|
14 |
13 |
$36.26 |
| 81025 |
|
12 |
12 |
$32.55 |
| 85652 |
|
14 |
14 |
$3.40 |
| A9270 |
Non-covered item or service |
43 |
12 |
$0.00 |